Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


suck pdf from google scholar
unlimited free pdf from europmc32490853    free
PDF from PMC    free
html from PMC    free
PDF vom PMID32490853  :  Publisher

suck abstract from ncbi

Nephropedia Template TP Text

Twit Text FOAVip

Twit Text #

English Wikipedia

  • Clinical decision support tool and rapid point-of-care platform for determining disease severity in patients with COVID-19 #MMPMID32490853
  • McRae MP; Simmons GW; Christodoulides NJ; Lu Z; Kang SK; Fenyo D; Alcorn T; Dapkins IP; Sharif I; Vurmaz D; Modak SS; Srinivasan K; Warhadpande S; Shrivastav R; McDevitt JT
  • Lab Chip 2020[Jun]; 20 (12): 2075-2085 PMID32490853show ga
  • SARS-CoV-2 is the virus that causes coronavirus disease (COVID-19) which has reached pandemic levels resulting in significant morbidity and mortality affecting every inhabited continent. The large number of patients requiring intensive care threatens to overwhelm healthcare systems globally. Likewise, there is a compelling need for a COVID-19 disease severity test to prioritize care and resources for patients at elevated risk of mortality. Here, an integrated point-of-care COVID-19 Severity Score and clinical decision support system is presented using biomarker measurements of C-reactive protein (CRP), N-terminus pro B type natriuretic peptide (NT-proBNP), myoglobin (MYO), D-dimer, procalcitonin (PCT), creatine kinase-myocardial band (CK-MB), and cardiac troponin I (cTnI). The COVID-19 Severity Score combines multiplex biomarker measurements and risk factors in a statistical learning algorithm to predict mortality. The COVID-19 Severity Score was trained and evaluated using data from 160 hospitalized COVID-19 patients from Wuhan, China. Our analysis finds that COVID-19 Severity Scores were significantly higher for the group that died versus the group that was discharged with median (interquartile range) scores of 59 (40-83) and 9 (6-17), respectively, and area under the curve of 0.94 (95% CI 0.89-0.99). Although this analysis represents patients with cardiac comorbidities (hypertension), the inclusion of biomarkers from other pathophysiologies implicated in COVID-19 (e.g., D-dimer for thrombotic events, CRP for infection or inflammation, and PCT for bacterial co-infection and sepsis) may improve future predictions for a more general population. These promising initial models pave the way for a point-of-care COVID-19 Severity Score system to impact patient care after further validation with externally collected clinical data. Clinical decision support tools for COVID-19 have strong potential to empower healthcare providers to save lives by prioritizing critical care in patients at high risk for adverse outcomes.
  • |*Point-of-Care Systems[MESH]
  • |Algorithms[MESH]
  • |Biomarkers[MESH]
  • |Comorbidity[MESH]
  • |Coronavirus Infections/*diagnosis/physiopathology[MESH]
  • |Critical Care[MESH]
  • |Decision Support Systems, Clinical/*organization & administration[MESH]
  • |Humans[MESH]
  • |Image Processing, Computer-Assisted[MESH]
  • |Immunoassay/methods[MESH]
  • |Machine Learning[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral/*diagnosis/physiopathology[MESH]
  • |Predictive Value of Tests[MESH]
  • |Risk Factors[MESH]
  • |Severity of Illness Index[MESH]
  • |Software[MESH]
  • |Treatment Outcome[MESH]

  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    2075 12.20 2020